1Cancer Epidemiology and Services Research, Sydney School of Public Health, University of Sydney, Sydney, New South Wales, Australia 2Cancer Institute of New South Wales, Everleigh, New South Wales, Australia 3Surgical Outcomes Research Centre, Sydney Local Health District, Sydney, New South Wales, Australia 4Department of Colorectal Surgery, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia 5Discipline of Surgery, Sydney School of Medicine, University of Sydney, Sydney, New South Wales, Australia.
Dis Colon Rectum. 2014 Apr;57(4):415-22. doi: 10.1097/DCR.0000000000000060.
Meta-analyses of randomized controlled trials support the use of laparoscopically assisted resection for colon cancer. The evidence supporting its use in rectal cancer is weak.
The purpose of this work was to investigate the uptake of laparoscopically assisted resection for colon and rectal cancer and to compare short- and long-term outcomes using population data.
This was a retrospective cohort study using linked administrative health data.
The study encompassed all of the public and private hospitals in New South Wales, Australia, between 2000 and 2008.
A total of 27,947 patients with colon or rectal cancer undergoing surgery with curative intent were included in the study.
We summarized the proportion of resections performed laparoscopically. Short-term outcomes were extended stay, 28-day readmission, 28-day emergency readmission, 30- and 90-day mortality, and 90-day readmission with pulmonary embolism or deep-vein thrombosis. Long-term outcomes were all-cause and cancer-specific death and admission with obstruction or incisional hernia repair.
Laparoscopic procedures increased between 2000 and 2008 for colon (1.5%-20.7%) and rectal cancer (0.6%-15.5%). Laparoscopic procedures reduced rates of extended stay (OR, 0.60; 95% CI, 0.49-0.72) and 28-day readmission (OR, 0.86; 95% CI, 0.74-0.99) for colon cancer. For rectal cancer, laparoscopic procedures had lower rates of 28-day readmission (OR, 0.58; 95% CI, 0.42-0.78) and 28-day emergency readmission (OR, 0.54; 95% CI, 0.34-0.85). Laparoscopic procedures improved cancer-specific survival for rectal cancer (HR, 0.71; 95% CI, 0.51-1.00). Survival benefits were observed for laparoscopically assisted colon resection in higher-caseload hospitals but not lower-caseload hospitals.
It was not possible to identify laparoscopically assisted resections converted to open procedures because of the claims-based nature of the data.
Despite increases in laparoscopically assisted resections for colon and rectal cancer, the majority of resections are still treated by open procedures. Our data suggest that laparoscopic resection reduces the lengths of stay and rates of readmission and may result in improved cancer-specific survival for both colon and rectal resections.
随机对照试验的荟萃分析支持使用腹腔镜辅助切除术治疗结肠癌。支持其用于直肠癌的证据较弱。
本研究旨在调查腹腔镜辅助结直肠癌切除术的应用情况,并利用人群数据比较短期和长期结果。
这是一项使用链接行政健康数据的回顾性队列研究。
本研究涵盖了澳大利亚新南威尔士州所有的公立和私立医院,时间范围为 2000 年至 2008 年。
共有 27947 名接受根治性手术的结肠癌或直肠癌患者纳入研究。
我们总结了腹腔镜手术的比例。短期结果包括住院时间延长、28 天再入院、28 天急诊再入院、30 天和 90 天死亡率以及 90 天内肺栓塞或深静脉血栓形成再入院。长期结果为全因和癌症特异性死亡以及肠梗阻或切口疝修补术的入院。
2000 年至 2008 年间,结肠癌(1.5%-20.7%)和直肠癌(0.6%-15.5%)的腹腔镜手术比例有所增加。腹腔镜手术降低了结肠癌患者住院时间延长(OR,0.60;95%CI,0.49-0.72)和 28 天再入院(OR,0.86;95%CI,0.74-0.99)的发生率。对于直肠癌,腹腔镜手术的 28 天再入院(OR,0.58;95%CI,0.42-0.78)和 28 天急诊再入院(OR,0.54;95%CI,0.34-0.85)发生率较低。腹腔镜手术提高了直肠癌的癌症特异性生存率(HR,0.71;95%CI,0.51-1.00)。在高病例量医院,腹腔镜辅助结直肠切除术有生存获益,但在低病例量医院则没有。
由于数据的索赔性质,无法确定腹腔镜辅助切除术转为开放手术的情况。
尽管结肠癌和直肠癌的腹腔镜辅助切除术有所增加,但大多数切除术仍采用开放手术。我们的数据表明,腹腔镜切除术可缩短住院时间和再入院率,并可能提高结直肠癌切除术的癌症特异性生存率。